VBIV: VBI Vaccines Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 18.63
Enterprise Value ($M) 45.72
Book Value ($M) 7.53
Book Value / Share 0.26
Price / Book 2.48
NCAV ($M) -43.19
NCAV / Share -1.51
Price / NCAV -0.43

Profitability (mra)
Return on Invested Capital (ROIC) -1.53
Return on Assets (ROA) -0.72
Return on Equity (ROE) -2.06

Liquidity (mrq)
Quick Ratio 0.37
Current Ratio 0.48

Balance Sheet (mrq) ($M)
Current Assets 36.23
Assets 86.95
Liabilities 79.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 8.68
Operating Income -55.31
Net Income -92.84
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -60.88
Cash from Investing -0.87
Cash from Financing 22.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-17 13D/A Perceptive Advisors Llc 4.40 -8.66
07-25 13D/A Arch Venture Fund Vi Lp
07-20 13G Brii Biosciences Ltd 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 59,906 142,844 41.94
2024-05-16 36,740 128,119 28.68
2024-05-15 105,820 240,307 44.04
2024-05-14 20,574 9,132 225.30
2024-05-13 50,665 135,943 37.27

(click for more detail)

Similar Companies
UNCY – Unicycive Therapeutics, Inc. UPC – Universe Pharmaceuticals INC
UPXI – Upexi, Inc. VCNX – Vaccinex, Inc.
VERU – Veru Inc.


Financial data and stock pages provided by
Fintel.io